Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2013

Nov 15, 2013

30718_dirs_2013-11-15_ad50e94c-c579-4423-80b4-d897fb16d6c5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-11-13

Reporting Person: STEER RANDOLPH C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-13 Common Stock M 5000 $66.59 Acquired 6000 Direct
2013-11-13 Common Stock M 5000 $65.47 Acquired 11000 Direct
2013-11-13 Common Stock M 5000 $63.03 Acquired 16000 Direct
2013-11-13 Common Stock S 15000 $86.2 Disposed 1000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-11-13 Stock Option $66.59 M 5000 Disposed 2017-10-24 Common Stock (5000) Direct
2013-11-13 Stock Option $65.47 M 5000 Disposed 2018-10-22 Common Stock (5000) Direct
2013-11-13 Stock Option $63.03 M 5000 Disposed 2019-10-28 Common Stock (5000) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $87.39 2023-10-30 Common Stock (4000) 4000 Direct
Stock Option $66.9 2022-10-24 Common Stock (5000) 5000 Direct
Stock Option $70.35 2021-10-26 Common Stock (5000) 5000 Direct
Stock Option $61.46 2020-10-27 Common Stock (5000) 5000 Direct